Coronavirus Main Proteinase: Target for Antiviral Drug Therapy

Kanchan Anand,Haitao Yang,Mark Bartlam,Zihe Rao,Rolf Hilgenfeld

DOI: https://doi.org/10.1007/3-7643-7339-3_9

2005-01-01

Abstract:During the first outbreak of severe acute respiratory syndrome (SARS) in early 2003, almost 8500 people worldwide were diagnosed with the disease, and approximately 800 died of it. The epidemic was contained by July, 2003, but since then, the disease has re-emerged in the Guangdong province in Southern China around the turn of the year 2003, although the number of cases was very limited this time. In addition, there were two cases of SARS caused by improper sample handling in research laboratories in Singapore and Taiwan. A “mini-outbreak” originated from several independent laboratory infections at a research laboratory in Beijing in March and April, 2004, and led to infection chains encompassing three generations.This time, China escaped another epidemic since fortunately, the number of diseased people was limited to nine, although there was one fatality. In any case, these isolated mini-outbreaks remind us of the global threat that SARS still represents. In late March, 2003, a new coronavirus, SARS-CoV, was isolated from affected tissue of SARS patients and identified as the cause of the disease [1, 2]. Coronaviridae are RNA viruses that have been united with the families Arteriviridae and Roniviridae in the order Nidovirales. The phylogenetic relationship of these morphologically unrelated virus families is based on their similar polycistronic genome organization, common transcriptional and post-translational strategies, and a conserved array of homologous domains in the viral polyproteins [3–5]. Coronaviruses are responsible for a number of diseases of man and animals, some of which have major economical impacts, although the human coronaviruses have clearly been neglected before SARS emerged. Transmissible gastroenteritis virus (TGEV) infection is associated with severe and often fatal diarrhoea in young pigs [6, 7]. The human coronaviruses (HCoV) 229E and OC43 are major causes Coronavirus main proteinase: target for antiviral drug therapy